DK175206B1 - Ekspressionskontrolsekvenser - Google Patents

Ekspressionskontrolsekvenser Download PDF

Info

Publication number: DK175206B1
Authority: DK; Denmark
Prior art keywords: dna sequence; promoter; gram; expression control; expression
Prior art date: 1985-07-05

Application number

DK198603206A

Other languages

Danish (da)

English (en)

Other versions

DK320686D0 (da

DK320686A (da

Inventor

Hermann Bujard

Stuart Le Grice

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-07-05

Filing date

1986-07-04

Publication date

2004-07-12

1986-07-04 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1986-07-04 Publication of DK320686D0 publication Critical patent/DK320686D0/da

1987-01-06 Publication of DK320686A publication Critical patent/DK320686A/da

2004-07-12 Application granted granted Critical

2004-07-12 Publication of DK175206B1 publication Critical patent/DK175206B1/da

Links

230000014509 gene expression Effects 0.000 title claims abstract description 43
108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 107
108090000623 proteins and genes Proteins 0.000 claims abstract description 62
239000013604 expression vector Substances 0.000 claims abstract description 38
238000000034 method Methods 0.000 claims abstract description 30
230000005030 transcription termination Effects 0.000 claims abstract description 26
229920001184 polypeptide Polymers 0.000 claims abstract description 17
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 17
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 17
238000013518 transcription Methods 0.000 claims abstract description 17
230000035897 transcription Effects 0.000 claims abstract description 16
238000004519 manufacturing process Methods 0.000 claims abstract description 4
239000013612 plasmid Substances 0.000 claims description 74
108020004414 DNA Proteins 0.000 claims description 69
235000014469 Bacillus subtilis Nutrition 0.000 claims description 56
241000588724 Escherichia coli Species 0.000 claims description 37
230000001580 bacterial effect Effects 0.000 claims description 34
239000013598 vector Substances 0.000 claims description 28
241000193830 Bacillus <bacterium> Species 0.000 claims description 19
108091026890 Coding region Proteins 0.000 claims description 19
108091008146 restriction endonucleases Proteins 0.000 claims description 19
239000013605 shuttle vector Substances 0.000 claims description 19
230000000977 initiatory effect Effects 0.000 claims description 9
230000003362 replicative effect Effects 0.000 claims description 8
244000063299 Bacillus subtilis Species 0.000 claims description 7
230000010076 replication Effects 0.000 claims description 6
108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 claims description 4
238000012270 DNA recombination Methods 0.000 claims description 4
241000192125 Firmicutes Species 0.000 claims description 4
241000701988 Escherichia virus T5 Species 0.000 claims description 3
101000966481 Mus musculus Dihydrofolate reductase Proteins 0.000 claims description 3
239000013599 cloning vector Substances 0.000 claims description 3
230000003115 biocidal effect Effects 0.000 claims description 2
102100025570 Cancer/testis antigen 1 Human genes 0.000 claims 2
101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 claims 2
241000701867 Enterobacteria phage T7 Species 0.000 claims 1
230000001131 transforming effect Effects 0.000 claims 1
102000004169 proteins and genes Human genes 0.000 abstract description 28
230000005026 transcription initiation Effects 0.000 abstract description 16
210000004027 cell Anatomy 0.000 description 31
229960005091 chloramphenicol Drugs 0.000 description 31
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 31
239000012634 fragment Substances 0.000 description 31
238000001962 electrophoresis Methods 0.000 description 25
238000010276 construction Methods 0.000 description 24
108020001507 fusion proteins Proteins 0.000 description 20
102000037865 fusion proteins Human genes 0.000 description 20
239000011543 agarose gel Substances 0.000 description 17
230000014616 translation Effects 0.000 description 17
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 16
229960005542 ethidium bromide Drugs 0.000 description 16
238000002844 melting Methods 0.000 description 16
230000008018 melting Effects 0.000 description 16
229920000936 Agarose Polymers 0.000 description 15
238000004458 analytical method Methods 0.000 description 13
230000015572 biosynthetic process Effects 0.000 description 12
238000003786 synthesis reaction Methods 0.000 description 12
238000013519 translation Methods 0.000 description 12
239000006142 Luria-Bertani Agar Substances 0.000 description 10
229930027917 kanamycin Natural products 0.000 description 10
229960000318 kanamycin Drugs 0.000 description 10
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 10
229930182823 kanamycin A Natural products 0.000 description 10
239000000499 gel Substances 0.000 description 9
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 8
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 8
108020005038 Terminator Codon Proteins 0.000 description 8
241000894006 Bacteria Species 0.000 description 7
101150055766 cat gene Proteins 0.000 description 7
101000897961 Rattus norvegicus Endothelial cell-specific molecule 1 Proteins 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
239000007788 liquid Substances 0.000 description 6
102100024746 Dihydrofolate reductase Human genes 0.000 description 5
238000003780 insertion Methods 0.000 description 5
230000037431 insertion Effects 0.000 description 5
239000002773 nucleotide Substances 0.000 description 5
125000003729 nucleotide group Chemical group 0.000 description 5
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 5
238000001243 protein synthesis Methods 0.000 description 5
108020004705 Codon Proteins 0.000 description 4
241000282326 Felis catus Species 0.000 description 4
241000297434 Stenotarsus subtilis Species 0.000 description 4
230000002068 genetic effect Effects 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
244000005700 microbiome Species 0.000 description 4
230000009466 transformation Effects 0.000 description 4
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
101100173636 Rattus norvegicus Fhl2 gene Proteins 0.000 description 3
108010022394 Threonine synthase Proteins 0.000 description 3
102000004419 dihydrofolate reductase Human genes 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
239000000203 mixture Substances 0.000 description 3
108020004707 nucleic acids Proteins 0.000 description 3
102000039446 nucleic acids Human genes 0.000 description 3
150000007523 nucleic acids Chemical class 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
238000006467 substitution reaction Methods 0.000 description 3
230000002103 transcriptional effect Effects 0.000 description 3
IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 3
229960001082 trimethoprim Drugs 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
101150074155 DHFR gene Proteins 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
206010059866 Drug resistance Diseases 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
239000002253 acid Substances 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
238000003556 assay Methods 0.000 description 2
238000000376 autoradiography Methods 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
238000010367 cloning Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000009585 enzyme analysis Methods 0.000 description 2
230000009969 flowable effect Effects 0.000 description 2
238000007429 general method Methods 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
239000012528 membrane Substances 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
210000001322 periplasm Anatomy 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
230000007017 scission Effects 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
230000014621 translational initiation Effects 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
108020004465 16S ribosomal RNA Proteins 0.000 description 1
FTMJFHVKAXPFIY-RKDXNWHRSA-N 2,2-dichloro-n-[(1r,2r)-1,3-dihydroxy-1-(3-nitrophenyl)propan-2-yl]acetamide Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=CC([N+]([O-])=O)=C1 FTMJFHVKAXPFIY-RKDXNWHRSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 1
101100323157 Arabidopsis thaliana LAP1 gene Proteins 0.000 description 1
241000304886 Bacilli Species 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
101000678026 Homo sapiens Alpha-1-antichymotrypsin Proteins 0.000 description 1
101001128634 Homo sapiens NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial Proteins 0.000 description 1
101000579218 Homo sapiens Renin Proteins 0.000 description 1
241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
108010074338 Lymphokines Proteins 0.000 description 1
102000008072 Lymphokines Human genes 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
102100032194 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial Human genes 0.000 description 1
241000282376 Panthera tigris Species 0.000 description 1
102000015731 Peptide Hormones Human genes 0.000 description 1
108010038988 Peptide Hormones Proteins 0.000 description 1
102000017143 RNA Polymerase I Human genes 0.000 description 1
108010013845 RNA Polymerase I Proteins 0.000 description 1
101100115246 Rattus norvegicus Cx3cr1 gene Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
108700009124 Transcription Initiation Site Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
108020002494 acetyltransferase Proteins 0.000 description 1
102000005421 acetyltransferase Human genes 0.000 description 1
239000012190 activator Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
230000001093 anti-cancer Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
102000006635 beta-lactamase Human genes 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
238000012258 culturing Methods 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
230000030609 dephosphorylation Effects 0.000 description 1
238000006209 dephosphorylation reaction Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
238000011049 filling Methods 0.000 description 1
229940044627 gamma-interferon Drugs 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000012215 gene cloning Methods 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
230000002519 immonomodulatory effect Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
108010070718 kanamycin nucleotidyltransferase Proteins 0.000 description 1
239000010410 layer Substances 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
201000004792 malaria Diseases 0.000 description 1
239000003550 marker Substances 0.000 description 1
239000002609 medium Substances 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
238000013492 plasmid preparation Methods 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000002028 premature Effects 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000000746 purification Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
108091007054 readthrough proteins Proteins 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
239000002356 single layer Substances 0.000 description 1
238000012360 testing method Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/832—Bacillus
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/848—Escherichia
- Y10S435/849—Escherichia coli

Landscapes

Genetics & Genomics (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Physics & Mathematics (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Enzymes And Modification Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK198603206A 1985-07-05 1986-07-04 Ekspressionskontrolsekvenser DK175206B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB8517071		1985-07-05
GB858517071A GB8517071D0 (en)	1985-07-05	1985-07-05	Gram-positive expression control sequence

Publications (3)

Publication Number	Publication Date
DK320686D0 DK320686D0 (da)	1986-07-04
DK320686A DK320686A (da)	1987-01-06
DK175206B1 true DK175206B1 (da)	2004-07-12

Family

ID=10581857

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK198603206A DK175206B1 (da)	1985-07-05	1986-07-04	Ekspressionskontrolsekvenser

Country Status (12)

Country	Link
US (1)	US4868111A (de)
EP (1)	EP0207459B1 (de)
JP (2)	JP2632809B2 (de)
AT (1)	ATE62020T1 (de)
AU (1)	AU594349B2 (de)
CA (1)	CA1316850C (de)
DE (1)	DE3678343D1 (de)
DK (1)	DK175206B1 (de)
GB (1)	GB8517071D0 (de)
IE (1)	IE59165B1 (de)
IL (1)	IL79291A (de)
NZ (1)	NZ216688A (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5266474A (en) *	1987-06-24	1993-11-30	Genentech, Inc.	Balanced inducible transcription system
DK443288A (da) *	1987-08-17	1989-02-18	Hoffmann La Roche	Ekspressionskontrolsekvenser
US5726042A (en) *	1988-04-07	1998-03-10	Abbott Laboratories	Expression of heterologous proteins in Bacillus megaterium utilizing sporulation promoters of Bacillus subtilis
GB8811761D0 (en) *	1988-05-18	1988-06-22	Thomae Gmbh Dr K	Biosynthetic process for preparation of chemical compounds
US7049102B1 (en)	1989-09-22	2006-05-23	Board Of Trustees Of Leland Stanford University	Multi-gene expression profile
FR2679568B1 (fr) *	1991-07-22	1994-09-02	Pasteur Institut	Nouveau type de replicon gram-positif - construction de vecteurs recombinants le contenant.
JPH07504815A (ja)	1992-02-27	1995-06-01	マイクロバイアル　テクニクス　リミティド	乳酸菌における異種遺伝子の発現およびその発現産物
US6022730A (en) *	1994-06-17	2000-02-08	Robinson; Douglas H.	Methods for the isolation of bacteria containing eukaryotic genes
US5629205A (en) *	1995-05-19	1997-05-13	Allelix Biopharmaceuticals Inc.	Promoters for gene expression
US6194168B1 (en) *	1997-09-30	2001-02-27	Human Genome Sciences, Inc.	Expression control sequences
US6146848A (en) *	1998-07-23	2000-11-14	The Hong Kong University Of Science & Technology	Bacterial expression system
US6720174B1 (en)	1999-01-28	2004-04-13	Novozymes A/S	Phytases
JP2002542169A (ja) *	1999-04-09	2002-12-10	テクラブ，インコーポレイテッド	Ｃｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅに対する、組換え毒素Ａ／毒素Ｂワクチン
ATE474932T1 (de) *	2000-10-25	2010-08-15	Fujifilm Corp	Methode zur analyse doppelsträngiger dna
WO2003065973A2 (en) *	2001-10-26	2003-08-14	Id Biomedical Corporation Of Washington	Multivalent streptococcal vaccine compositions and methods for use
US9453251B2 (en)	2002-10-08	2016-09-27	Pfenex Inc.	Expression of mammalian proteins in Pseudomonas fluorescens
CA2545610C (en)	2003-11-19	2014-03-25	Dow Global Technolgies Inc.	Auxotrophic pseudomonas fluorescens bacteria for recombinant protein expression
AU2004317306B2 (en)	2003-11-21	2010-09-02	Pelican Technology Holdings, Inc.	Improved expression systems with Sec-system secretion
ES2663594T3 (es)	2004-01-16	2018-04-16	Pfenex Inc	Expresión de proteínas de mamífero en Pseudomonas fluorescens
US8603824B2 (en)	2004-07-26	2013-12-10	Pfenex, Inc.	Process for improved protein expression by strain engineering
GB0602173D0 (en) *	2006-02-03	2006-03-15	Avecia Ltd	Expression system
PT2086642E (pt)	2006-10-18	2014-09-30	Periness Ltd	Dnase para o tratamento de subfertilidade masculina
JP5714230B2 (ja)	2007-01-31	2015-05-07	フェネックスインコーポレイテッド	発現上昇のための細菌リーダー配列
US9580719B2 (en)	2007-04-27	2017-02-28	Pfenex, Inc.	Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
JP5444553B2 (ja)	2007-04-27	2014-03-19	フェネックスインコーポレイテッド	微生物宿主を迅速にスクリーニングして、異種タンパク質発現の収率および／または質が改善されている特定の株を同定する方法
WO2010132341A2 (en)	2009-05-11	2010-11-18	Pfenex, Inc.	Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
WO2011109556A2 (en)	2010-03-04	2011-09-09	Pfenex Inc.	Method for producing soluble recombinant interferon protein without denaturing
EP2553102B1 (de)	2010-03-30	2015-12-09	Pfenex Inc.	Hochleistungs-expression rekombinanter toxinproteine
NZ603033A (en)	2010-04-01	2014-06-27	Pfenex Inc	Methods for g-csf production in a pseudomonas host cell
US9169304B2 (en)	2012-05-01	2015-10-27	Pfenex Inc.	Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
US11408007B2 (en)	2014-09-26	2022-08-09	Yale University	Compositions and methods for biocontainment of microorganisms
JP6817939B2 (ja)	2014-12-01	2021-01-20	フェネックスインク．	ペプチド産生のための融合パートナー
AU2018354069A1 (en)	2017-10-27	2020-06-11	Pelican Technology Holdings, Inc.	Bacterial leader sequences for periplasmic protein expression
JP7784804B2 (ja)	2017-10-27	2025-12-12	フェネックスインク．	組み換えｅｒｗｉｎｉａアスパラギナーゼの製造のための方法
WO2019083794A1 (en)	2017-10-27	2019-05-02	Pfenex Inc.	PROCESS FOR PRODUCING EAR ASPARAGINASE. RECOMBINED COLI
US11149280B2 (en)	2019-10-29	2021-10-19	Yale University	Engineering organisms resistant to viruses and horizontally transferred genetic elements
WO2022211829A1 (en)	2021-03-30	2022-10-06	Jazz Pharmaceuticals Ireland Ltd.	Dosing of recombinant l-asparaginase
EP4493688A2 (de)	2022-03-17	2025-01-22	Yale University	Zusammensetzungen und verfahren zur expression synthetischer genetischer elemente über verschiedene mikroorganismen hinweg
CN117384923A (zh) *	2023-09-13	2024-01-12	深圳先进技术研究院	表达盒、表达载体、重组微生物、非核糖体肽合成基因簇的异源表达方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4495280A (en) *	1981-05-20	1985-01-22	The Board Of Trustees Of The Leland Stanford Jr. University	Cloned high signal strength promoters
GR81701B (de)	1983-01-18	1984-12-12	Lilly Co Eli
EP0115936A1 (de) *	1983-01-24	1984-08-15	Kabushiki Kaisha Yakult Honsha	Chimere Plasmide

1985
- 1985-07-05 GB GB858517071A patent/GB8517071D0/en active Pending
1986
- 1986-06-17 US US07/875,437 patent/US4868111A/en not_active Expired - Fee Related
- 1986-06-27 NZ NZ216688A patent/NZ216688A/xx unknown
- 1986-06-27 DE DE8686108774T patent/DE3678343D1/de not_active Expired - Lifetime
- 1986-06-27 EP EP86108774A patent/EP0207459B1/de not_active Expired - Lifetime
- 1986-06-27 AT AT86108774T patent/ATE62020T1/de not_active IP Right Cessation
- 1986-06-30 AU AU59385/86A patent/AU594349B2/en not_active Expired
- 1986-06-30 IL IL79291A patent/IL79291A/xx not_active IP Right Cessation
- 1986-07-04 JP JP61157771A patent/JP2632809B2/ja not_active Expired - Lifetime
- 1986-07-04 DK DK198603206A patent/DK175206B1/da not_active IP Right Cessation
- 1986-07-04 CA CA000513094A patent/CA1316850C/en not_active Expired - Lifetime
- 1986-07-04 IE IE180686A patent/IE59165B1/en not_active IP Right Cessation
1996
- 1996-07-16 JP JP8185740A patent/JP2887248B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP2887248B2 (ja)	1999-04-26
AU594349B2 (en)	1990-03-08
NZ216688A (en)	1990-06-26
DE3678343D1 (de)	1991-05-02
JP2632809B2 (ja)	1997-07-23
DK320686D0 (da)	1986-07-04
CA1316850C (en)	1993-04-27
EP0207459B1 (de)	1991-03-27
AU5938586A (en)	1987-01-08
IL79291A0 (en)	1986-09-30
IE59165B1 (en)	1994-01-12
IE861806L (en)	1987-01-05
JPS6214786A (ja)	1987-01-23
IL79291A (en)	1991-06-30
JPH10229878A (ja)	1998-09-02
DK320686A (da)	1987-01-06
GB8517071D0 (en)	1985-08-14
EP0207459A2 (de)	1987-01-07
ATE62020T1 (de)	1991-04-15
US4868111A (en)	1989-09-19
EP0207459A3 (en)	1988-07-06

Legal Events

Date	Code	Title	Description
2006-07-24	PUP	Patent expired

Publication	Publication Date	Title
DK175206B1 (da)	2004-07-12	Ekspressionskontrolsekvenser
Kaster et al.	1983	Analysis of a bacterial hygromycin B resistance gene by transcriptional and translational fusions and by DNA sequencing
Baty et al.	1987	Extracellular release of colicin A is non‐specific.
EP0410655A1 (de)	1991-01-30	Expressionskontrolle heterologer Gene von LAC-gesteuerten Promotoren
Hamilton et al.	1985	Structure of genes and an insertion element in the methane producing archaebacterium Methanobrevibacter smithii
HUT57263A (en)	1991-11-28	Process for producing bacterial vectors
Ishino et al.	1986	Nucleotide sequence of the lig gene and primary structure of DNA ligase of Escherichia coli
Kovacevic et al.	1985	Secretion of staphylococcal nuclease by Bacillus subtilis
Schottel et al.	1984	Effects of alterations in the translation control region on bacterial gene expression: use of cat gene constructs transcribed from the lac promoter as a model system
EP0821063B1 (de)	2003-12-10	Verbesserte Riboflavin-Herstellung
US5726039A (en)	1998-03-10	Vectors and transformed host cells for recombinant protein production at reduced temperatures
JPS62181789A (ja)	1987-08-10	バチルスの制御領域のクロ−ニング及び解析のためのプラスミド
Zaghloul et al.	1985	Translational coupling in Bacillus subtilis of a heterologous Bacillus subtilis-Escherichia coli gene fusion
Ludtke et al.	1984	Identification of the phoM gene product and its regulation in Escherichia coli K-12
US6617130B1 (en)	2003-09-09	DNA construct for regulating the expression of a polypeptide coding sequence in a transformed bacterial host cell
Shimizu et al.	1991	Identification of the promoter region of the ribosome-releasing factor cistron (frr)
EP0134673B1 (de)	1991-10-09	Plasmidvektor und seine Verwendung
US7868148B2 (en)	2011-01-11	Plasmids, their derivatives and fragments, their methods of manufacture and application
US5654169A (en)	1997-08-05	Vectors and transformed host cells for recombinant protein production at reduced temperatures
EP0186069B1 (de)	1992-02-19	Expressionskontrollsequenzen
US5212083A (en)	1993-05-18	Sequence for stabilizing proteins in bacteria
EP0182562A2 (de)	1986-05-28	Verfahren zur thermoinduzierbaren Genexpression in grampositiven Bakterien, Bacillus subtilis Stämme, die Plasmide enthalten, die eine solche Expression induzieren und portable Vektor-Systeme
Birkmann et al.	1989	Construction of chimaeric promoter regions by exchange of the upstream regulatory sequences from fdhF and nif genes
Brevet et al.	1985	Tn 7-encoded proteins
JP2558249B2 (ja)	1996-11-27	正のレトロレギユレーシヨン因子